GABPB1 and Alzheimer disease: Reduced levels of p62 in the frontal cortex of AD patients and in AD model mice were suggested to be responsible for a decreased nuclear respiratory factor 2-dependent antioxidant response that leads to impaired oxidative stress resistance, thereby contributing to AD pathology [89].